Related references
Note: Only part of the references are listed.The evaluation of potent antitumor activities of shikonin coumarin-carboxylic acid, PMMB232 through HIF-1α-mediated apoptosis
Hong-Wei Han et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Development of novel synthesized phthalazinone-based PARP-1 inhibitors with apoptosis inducing mechanism in lung cancer
Hadia Almahli et al.
BIOORGANIC CHEMISTRY (2018)
Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome
Rita Assi et al.
CANCER (2018)
Structural investigations on coumarins leading to chromeno[4,3-c] pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII
Alessandro Bonardi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Novel coumarin- and quinolinone-based polycycles as cell division cycle 25-A and -C phosphatases inhibitors induce proliferation arrest and apoptosis in cancer cells
Clemens Zwergel et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene) amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies
Wagdy M. Eldehna et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis and biological evaluation of fluorinated N-benzoyl and N-phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7-O-sulfamate as steroid sulfatase inhibitors
Mateusz Dasko et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDA-MB-231 cells
Wagdy M. Eldehna et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents
Wagdy M. Eldehn et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
New hydrazonoindolin-2-ones: Synthesis, exploration of the possible anti-proliferative mechanism of action and encapsulation into PLGA microspheres
Mohamed I. Attia et al.
PLOS ONE (2017)
Synthesis and Biological Evaluation of Fluorinated 3-Phenylcoumarin-7-O-Sulfamate Derivatives as Steroid Sulfatase Inhibitors
Sebastian Demkowicz et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2016)
Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII
Navneet Chandak et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Coumarin sulfonamides derivatives as potent and selective COX-2 inhibitors with efficacy in suppressing cancer proliferation and metastasis
Xiao-Yuan Lu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers
Mostafa M. Ghorab et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Triazole tethered C5-curcuminoid-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies
Harbinder Singh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Therapeutic potential of coumarins as antiviral agents
Mohd. Zaheen Hassan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Recent developments of C-4 substituted coumarin derivatives as anticancer agents
Jyoti Dandriyal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors
Dong Cao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Synthesis and Human Anticancer Cell Line Studies on Coumarin-β-carboline Hybrids as Possible Antimitotic Agents
S. Samundeeswari et al.
CHEMISTRYSELECT (2016)
Coumarin: A Promising Scaffold for Anticancer Agents
Manjinder Kaur et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2015)
Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones
Wagdy M. Eldehna et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Coumarins as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies
Anuradha Thakur et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Investigation of (E)-344-(2-Oxo-3-aryl-chromen-4-yl)oxyphenyl]acrylic Acids as Oral Selective Estrogen Receptor Down-Regulators
Sebastien L. Degorce et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Coumarins as privileged scaffold for anti-inflammatory drug development
Jagdeep Grover et al.
RSC ADVANCES (2015)
A Novel Coumarin-Quinone Derivative SV37 Inhibits CDC25 Phosphatases, Impairs Proliferation, and Induces Cell Death
Emilie Bana et al.
MOLECULAR CARCINOGENESIS (2015)
Synthesis and tumor inhibitory activity of novel coumarin analogs targeting angiogenesis and apoptosis
B. R. Vijay Avin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Hybrids of Phenylsulfonylfuroxan and Coumarin as Potent Antitumor Agents
Ming-Ming Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Synthesis and Biological Evaluations of 3-Benzothiazol-2-yl Coumarin Derivatives as MEK1 Inhibitors
Chao Wang et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2013)
Novel microtubule-targeted agent 6-chloro-4-(methoxyphenyl) coumarin induces G2-M arrest and apoptosis in HeLa cells
Yi-ming Ma et al.
ACTA PHARMACOLOGICA SINICA (2012)
Therapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatment
Yoichi Ozawa et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP
Shaoman Yin et al.
CLINICAL CANCER RESEARCH (2012)
KCN1, a Novel Synthetic Sulfonamide Anticancer Agent: In Vitro and In Vivo Anti-Pancreatic Cancer Activities and Preclinical Pharmacology
Wei Wang et al.
PLOS ONE (2012)
Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX Inhibitors
Yuanmei Lou et al.
CANCER RESEARCH (2011)
Irosustat: a first-generation steroid sulfatase inhibitor in breast cancer
Carlo Palmieri et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
Anti-breast cancer potential of SS5020, a novel benzopyran antiestrogen
Naomi Suzuki et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis
Fabio Pacchiano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases
Sergio Valente et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
Musiliyu A. Musa et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Single and multiple ascending dose studies of a novel tissue-selective oestrogen receptor modulator, CHF 4227, in healthy postmenopausal women
Maurizio Civelli et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Identification of coumarin derivatives as a novel class of allosteric MEK1 inhibitors
SL Han et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Synthesis of new coumarin 3-(N-aryl) sulfonamides and their anticancer activity
NS Reddy et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Biochemical and biological characterization of a novel anti-aromatase coumarin derivative
SU Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Anticancer therapy targeting the apoptotic pathway
W Hu et al.
LANCET ONCOLOGY (2003)
E7070, a novel sulphonamide agent with potent antitumour activity in vitro and in vivo
Y Ozawa et al.
EUROPEAN JOURNAL OF CANCER (2001)
Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells
K Fukuoka et al.
INVESTIGATIONAL NEW DRUGS (2001)
Share Paper
